Pediatría
Tratamiento de la ictericia neonatal en recién nacidos a término. Experiencia del Hospital Central de Maracay
Referencias
1.Provisional Committee for Quality Improvement; Subcommittee on Hyperbilirrubinemia. Practice Parameter: Management of Hyperbilirrubinemia in the Healthy Term Newborn. Pediatrics 1994; 94: 558-565
2.Subcommitte on Hyperbilirrubinemia. Management of Hyperbilirrubinemia in the Newborn Infant 35 or more weeks of gestation. Pediatrics 2004; 114; 297-316
3.Atkinson R, Escobar G, Takayama J, Newman T. Phototherapy Use in Jaundiced Newborns in a Large Managed Care Organization: Do Clinicians Adhere to the Guideline? Pediatrics 2003;111; e555-e561
4. Sarici U, Serdar M, Korkmanz A, Erdem G, Oran O, et al. Incidence, Course, and Prediction of Hyperbilirubinemia in Near-Term and Term Newborn. Pediatrics 2004;113; 775-780
5. Bruke B, Robbins J, Mac Bird T, Hobbs C, Nesmith C, Mick J. Trends in Hospitalizations for Neonatal Jaundice and Kernicterus in the United States, 1988 2005. Pediatrics 2009; 123; 524-532.
6. Péon-Hidalgo L, Pacheco M, Zavala-Ruiz M, Madueño-Lopez A, García-Gonzalez A. Frecuencias de Grupos Sanguíneos e incompatibilidades ABO y RhD en La Paz, Baja California Sur, México. Salud Pública de México 2002; 44 (5): 406-412 |
